India's shortage of remdesivir is easing, Goa plant to ramp up production: Cipla

Remdesivir, made by U.S.-based Gilead Sciences Inc, has been in high demand globally, and a handful of companies including Cipla are authorised to make and sell generic versions in 127 developing nations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XPvEF0
via IFTTT